Small-molecule compounds (Fig. 8A), such as SY14 and THF2, with numerous targets and a therapeutic effect on the targets, were included in the follow-up analysis to interpret the mechanism by which they combat psoriasis. The gene discussed is CCL14; the disease is psoriasis.